Abdominal Wall Unit, Department of Surgery, J. M. Morales Meseguer Hospital, Avenida Primo de Rivera 7, 5º D, Edif, 30008, Murcia, Berlin, Spain.
Surg Endosc. 2012 Apr;26(4):1069-78. doi: 10.1007/s00464-011-2001-x. Epub 2011 Nov 1.
The role of the laparoscopic approach in the repair of non-midline incisional hernias is controversial due to the absence of adequate scientific studies. This study aimed to determine the safety and efficacy of laparoscopic repair for non-midline incisional hernias.
This prospective clinical study was conducted in an abdominal wall unit of a teaching hospital. Patients underwent surgery for non-midline incisional hernias using the laparoscopic approach (n = 73) and were classified into three groups: subcostal, iliac, and lumbar. The primary end point was recurrence. The secondary end points were intraoperative parameters, comorbidity, and patient outcomes. The median follow-up period was 62 months (range, 36-170 months).
No hospital stay was needed for 34% of the patients. The remaining patients needed an average hospital stay of 2.7 days. The most frequent morbidity was hematoma. The overall recurrence rate was 8.2% and was higher for the subcostal hernias (25%). The three groups differed in size, local morbidity, and recurrence (P < 0.05). The independent risk factors for recurrence were size (hazard ratio [HR], 2.16; 95% confidence interval [CI], 1.08-4.33) and local morbidity (HR 30.62; 95% CI 1.22-768-82). The best predictor of recurrence was a hernia diameter greater than 15 cm. The only predictive factor of local morbidity was obesity (P < 0.007).
The laparoscopic approach is a safe and effective treatment for non-midline incisional hernias. Caution should be taken with subcostal hernias, obese patients, and a defect size greater than 15 cm. An algorithm is suggested to guide the "rational" treatment of non-midline incisional hernias.
由于缺乏充分的科学研究,腹腔镜方法在修复非中线切口疝中的作用存在争议。本研究旨在确定腹腔镜修复非中线切口疝的安全性和有效性。
这是一项在教学医院腹壁单元进行的前瞻性临床研究。患者接受腹腔镜方法治疗非中线切口疝(n=73),并分为肋缘下、髂嵴和腰疝三组。主要终点是复发。次要终点是术中参数、合并症和患者结局。中位随访时间为 62 个月(范围 36-170 个月)。
34%的患者无需住院,其余患者平均住院 2.7 天。最常见的并发症是血肿。总体复发率为 8.2%,肋缘下疝的复发率更高(25%)。三组在大小、局部并发症和复发方面存在差异(P<0.05)。复发的独立危险因素是大小(风险比[HR],2.16;95%置信区间[CI],1.08-4.33)和局部并发症(HR 30.62;95%CI 1.22-768-82)。复发的最佳预测因素是疝直径大于 15cm。局部并发症的唯一预测因素是肥胖(P<0.007)。
腹腔镜方法是治疗非中线切口疝的一种安全有效的方法。对于肋缘下疝、肥胖患者和大于 15cm 的缺损,应谨慎处理。建议制定一种算法来指导非中线切口疝的“合理”治疗。